{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ADM&page=11", "query": { "intervention": "ADM", "page": 11 }, "page_size": 10 }, "pagination": { "page": 11, "page_size": 10, "total_count": 4268, "total_pages": 427, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ADM&page=12&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ADM&page=10&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-12T09:57:13.174Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03422276", "title": "Brain Injury Rehabilitation Improving the Transition Experience", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Traumatic Brain Injury" ], "interventions": [ { "name": "Rehabilitation Discharge Plan", "type": "OTHER" }, { "name": "Rehabilitation Transition Plan", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1555, "start_date": "2018-02-13", "completion_date": "2022-11-10", "has_results": true, "last_update_posted_date": "2025-03-12", "last_synced_at": "2026-11-12T09:57:13.174Z", "location_count": 6, "location_summary": "Indianapolis, Indiana • New York, New York • Columbus, Ohio + 3 more", "locations": [ { "city": "Indianapolis", "state": "Indiana" }, { "city": "New York", "state": "New York" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Elkins Park", "state": "Pennsylvania" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03422276" }, { "nct_id": "NCT07075718", "title": "Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Glaucoma" ], "interventions": [ { "name": "Gen 2 Travoprost Intracameral Implant", "type": "DRUG" }, { "name": "Timolol eye drops 0.5%", "type": "DRUG" }, { "name": "Sham Procedure", "type": "PROCEDURE" }, { "name": "Placebo eye drops", "type": "OTHER" } ], "intervention_types": [ "DRUG", "PROCEDURE", "OTHER" ], "sponsor": "Glaukos Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 110, "start_date": "2025-06-12", "completion_date": "2032-03", "has_results": false, "last_update_posted_date": "2026-09-17", "last_synced_at": "2026-11-12T09:57:13.174Z", "location_count": 3, "location_summary": "Grand Junction, Colorado • Oklahoma City, Oklahoma • El Paso, Texas", "locations": [ { "city": "Grand Junction", "state": "Colorado" }, { "city": "Oklahoma City", "state": "Oklahoma" }, { "city": "El Paso", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07075718" }, { "nct_id": "NCT05466682", "title": "RELAXaHEAD for Headache Patients (Phase II)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Migraine", "Headache", "Multiple Sclerosis", "Insomnia" ], "interventions": [ { "name": "Smartphone-Based Progressive Muscle Relaxation Therapy (PMR)", "type": "BEHAVIORAL" }, { "name": "Monitored Usual Care (MUC)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 48, "start_date": "2022-06-09", "completion_date": "2023-06-19", "has_results": true, "last_update_posted_date": "2024-01-10", "last_synced_at": "2026-11-12T09:57:13.174Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05466682" }, { "nct_id": "NCT01705691", "title": "Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Cancer", "HER2-negative Breast Cancer" ], "interventions": [ { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Eribulin", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NSABP Foundation Inc", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 50, "start_date": "2012-09", "completion_date": "2015-10", "has_results": true, "last_update_posted_date": "2021-10-06", "last_synced_at": "2026-11-12T09:57:13.174Z", "location_count": 18, "location_summary": "Denver, Colorado • Miami Beach, Florida • Albany, Georgia + 13 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Miami Beach", "state": "Florida" }, { "city": "Albany", "state": "Georgia" }, { "city": "Savannah", "state": "Georgia" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01705691" }, { "nct_id": "NCT00706823", "title": "Comparison of I-gel to the Laryngeal Mask Airway", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Endotracheal Intubation", "Supraglottic Airway" ], "interventions": [ { "name": "i-gel airway (Intersurgical Ltd., Wokingham, England)", "type": "DEVICE" }, { "name": "Laryngeal Mask Airway-Unique", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 50, "start_date": "2008-02", "completion_date": "2008-08", "has_results": true, "last_update_posted_date": "2017-02-20", "last_synced_at": "2026-11-12T09:57:13.174Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00706823" }, { "nct_id": "NCT01952743", "title": "Renal Denervation Therapy in Hypertensive Patients Undergoing A-Fib Ablation", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Atrial Fibrillation", "Hypertension" ], "interventions": [ { "name": "AF ablation with Renal Denervation", "type": "PROCEDURE" }, { "name": "AF ablation alone", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Siva Mulpuru", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3, "start_date": "2013-09", "completion_date": "2015-10", "has_results": false, "last_update_posted_date": "2017-03-22", "last_synced_at": "2026-11-12T09:57:13.174Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01952743" }, { "nct_id": "NCT01191021", "title": "Monitoring Exhaled Propofol to Individualize General Anesthesia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "General Anesthesia" ], "interventions": [ { "name": "Propofol Anesthesia", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2010-08", "completion_date": "2010-10", "has_results": false, "last_update_posted_date": "2013-06-05", "last_synced_at": "2026-11-12T09:57:13.174Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01191021" }, { "nct_id": "NCT07159633", "title": "OurRelationship-S: A Digital Relationship-Strengthening Program for Couples Experiencing Substance Misuse", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Relationship Conflict", "Relationship Distress" ], "interventions": [ { "name": "Online Couple Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "OurRelationship", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 120, "start_date": "2025-02-15", "completion_date": "2025-12-31", "has_results": false, "last_update_posted_date": "2025-09-08", "last_synced_at": "2026-11-12T09:57:13.174Z", "location_count": 5, "location_summary": "Marietta, Georgia • Elkton, Maryland • Potsdam, New York + 2 more", "locations": [ { "city": "Marietta", "state": "Georgia" }, { "city": "Elkton", "state": "Maryland" }, { "city": "Potsdam", "state": "New York" }, { "city": "Lexington", "state": "South Carolina" }, { "city": "Coppell", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07159633" }, { "nct_id": "NCT06058949", "title": "Health Protection and Promotion of Sign Language Interpreters Through Implementation of Total Worker Health®", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Well-Being, Psychological" ], "interventions": [ { "name": "Health Protection and Promotion", "type": "BEHAVIORAL" }, { "name": "General Health Program", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Rochester", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 118, "start_date": "2024-05-01", "completion_date": "2026-08-31", "has_results": false, "last_update_posted_date": "2026-09-22", "last_synced_at": "2026-11-12T09:57:13.174Z", "location_count": 1, "location_summary": "Rochester, New York", "locations": [ { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06058949" }, { "nct_id": "NCT00933985", "title": "Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Acute Leukemias of Ambiguous Lineage", "Acute Undifferentiated Leukemia", "Angioimmunoblastic T-cell Lymphoma", "Blastic Phase Chronic Myelogenous Leukemia", "Childhood Burkitt Lymphoma", "Childhood Chronic Myelogenous Leukemia", "Childhood Diffuse Large Cell Lymphoma", "Childhood Immunoblastic Large Cell Lymphoma", "Childhood Nasal Type Extranodal NK/T-cell Lymphoma", "Cutaneous B-cell Non-Hodgkin Lymphoma", "Hepatosplenic T-cell Lymphoma", "Intraocular Lymphoma", "Noncutaneous Extranodal Lymphoma", "Peripheral T-cell Lymphoma", "Recurrent Childhood Acute Lymphoblastic Leukemia", "Recurrent Childhood Acute Myeloid Leukemia", "Recurrent Childhood Anaplastic Large Cell Lymphoma", "Recurrent Childhood Grade III Lymphomatoid Granulomatosis", "Recurrent Childhood Large Cell Lymphoma", "Recurrent Childhood Lymphoblastic Lymphoma", "Recurrent Childhood Small Noncleaved Cell Lymphoma", "Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma", "Recurrent Mycosis Fungoides/Sezary Syndrome", "Recurrent/Refractory Childhood Hodgkin Lymphoma", "Refractory Chronic Lymphocytic Leukemia", "Refractory Hairy Cell Leukemia", "Relapsing Chronic Myelogenous Leukemia", "Small Intestine Lymphoma", "Unspecified Childhood Solid Tumor, Protocol Specific" ], "interventions": [ { "name": "dexrazoxane hydrochloride", "type": "DRUG" }, { "name": "doxorubicin hydrochloride", "type": "DRUG" }, { "name": "obatoclax mesylate", "type": "DRUG" }, { "name": "liposomal vincristine sulfate", "type": "DRUG" }, { "name": "pharmacological study", "type": "OTHER" }, { "name": "laboratory biomarker analysis", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "21 Years", "sex": "ALL", "summary": "Up to 21 Years" }, "enrollment_count": 22, "start_date": "2009-06", "completion_date": "2013-04", "has_results": false, "last_update_posted_date": "2014-05-01", "last_synced_at": "2026-11-12T09:57:13.174Z", "location_count": 18, "location_summary": "Birmingham, Alabama • Orange, California • Washington D.C., District of Columbia + 15 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Orange", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00933985" } ] }